How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?
Kjetil Herland(NTNU Samfunnsforskning), Leif Bjermer(Lund University), Jan-Petter Akselsen, Ole Henning Skjønsberg(Oslo University Hospital)
Cited by 317
Related Papers
MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
|Journal of Allergy and Clinical Immunology|2010|578
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels
|CHEST Journal|2016|426
EUFOREA consensus on biologics for CRSwNP with or without asthma
|Allergy|2019|378
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329
Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)
|European Respiratory Journal|2015|322